# Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia

> **NCT00753324** · PHASE4 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 284 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Routine three-drug antiretroviral prophylaxis

## Key facts

- **NCT ID:** NCT00753324
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2016-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00753324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00753324, "Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00753324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*